677 related articles for article (PubMed ID: 21533301)
1. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial.
Miller DW; Koch SB; Yentzer BA; Clark AR; O'Neill JR; Fountain J; Weber TM; Fleischer AB
J Drugs Dermatol; 2011 May; 10(5):531-7. PubMed ID: 21533301
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness study of pediatric atopic dermatitis in Asia: atopiclair vs. regular emollient (AD-ATOP).
Tang MB; Leong KF; Ou LS; Munasir Z; Parekh PR; Azmi S; Low WH; Goh A
J Drugs Dermatol; 2015 Feb; 14(2):169-75. PubMed ID: 25689812
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of a cream containing AR-GG27® (sorbityl furfural palmitate) in the treatment of mild/moderate childhood atopic dermatitis associated with pityriasis alba. A double-blind, placebo-controlled clinical trial.
Patrizi A; Raone B; Raboni R; Neri I
G Ital Dermatol Venereol; 2012 Dec; 147(6 Suppl 1):1-8. PubMed ID: 23007324
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults.
Abramovits W; Hebert AA; Boguniewicz M; Kempers SE; Tschen E; Jarratt MT; Lucky AW; Cornelison RL; Swinyer LJ; Jones TM
J Dermatolog Treat; 2008; 19(6):327-32. PubMed ID: 18728923
[TBL] [Abstract][Full Text] [Related]
5. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pruritus in mild-to-moderate atopic dermatitis with a topical non-steroidal agent.
Veraldi S; De Micheli P; Schianchi R; Lunardon L
J Drugs Dermatol; 2009 Jun; 8(6):537-9. PubMed ID: 19537379
[TBL] [Abstract][Full Text] [Related]
7. A clinical evaluation of the comparable efficacy of hyaluronic acid-based foam and ceramide-containing emulsion cream in the treatment of mild-to-moderate atopic dermatitis.
Draelos ZD
J Cosmet Dermatol; 2011 Sep; 10(3):185-8. PubMed ID: 21896129
[TBL] [Abstract][Full Text] [Related]
8. Barrier-repair prescription moisturizers: do we really need them? Facts and controversies.
Wolf R; Parish LC
Clin Dermatol; 2013; 31(6):787-91. PubMed ID: 24160288
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.
Abramovits W; Boguniewicz M;
J Drugs Dermatol; 2006 Mar; 5(3):236-44. PubMed ID: 16573256
[TBL] [Abstract][Full Text] [Related]
10. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.
Frankel A; Sohn A; Patel RV; Lebwohl M
J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908
[TBL] [Abstract][Full Text] [Related]
11. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study.
Boguniewicz M; Zeichner JA; Eichenfield LF; Hebert AA; Jarratt M; Lucky AW; Paller AS
J Pediatr; 2008 Jun; 152(6):854-9. PubMed ID: 18492531
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR) in the management of atopic dermatitis in paediatric patients.
Patrizi A; Capitanio B; Neri I; Giacomini F; Sinagra JL; Raone B; Berardesca E
Pediatr Allergy Immunol; 2008 Nov; 19(7):619-25. PubMed ID: 18298424
[TBL] [Abstract][Full Text] [Related]
13. A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis.
Bissonnette R; Maari C; Provost N; Bolduc C; Nigen S; Rougier A; Seite S
J Cosmet Dermatol; 2010 Mar; 9(1):16-21. PubMed ID: 20367668
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of an over-the-counter 1% colloidal oatmeal cream in the management of mild to moderate atopic dermatitis in children: a double-blind, randomized, active-controlled study.
Lisante TA; Nuñez C; Zhang P
J Dermatolog Treat; 2017 Nov; 28(7):659-667. PubMed ID: 28366039
[TBL] [Abstract][Full Text] [Related]
15. Case studies assessing a new skin barrier repair cream for the treatment of atopic dermatitis.
Bikowski J
J Drugs Dermatol; 2009 Nov; 8(11):1037-41. PubMed ID: 19894374
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
[TBL] [Abstract][Full Text] [Related]
17. A new moisturizer containing physiologic lipid granules alleviates atopic dermatitis.
Na JI; Hwang JS; Park HJ; Kim DH; Park WS; Youn SW; Huh CH; Park KC
J Dermatolog Treat; 2010 Jan; 21(1):23-7. PubMed ID: 19626524
[TBL] [Abstract][Full Text] [Related]
18. A 1% colloidal oatmeal OTC cream is clinically effective for the management of mild to moderate atopic dermatitis in Black or African American children.
Lisante TA; Kizoulis M; Nuñez C; Hartman CL
J Dermatolog Treat; 2023 Dec; 34(1):2241587. PubMed ID: 37592879
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind, split-side, comparison study of moisturizer containing licochalcone A and 1% hydrocortisone in the treatment of childhood atopic dermatitis.
Wananukul S; Chatproedprai S; Chunharas A; Limpongsanuruk W; Singalavanija S; Nitiyarom R; Wisuthsarewong W
J Med Assoc Thai; 2013 Sep; 96(9):1135-42. PubMed ID: 24163988
[TBL] [Abstract][Full Text] [Related]
20. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial.
Canpolat F; Erkoçoğlu M; Tezer H; Kocabaş CN; Kandi B
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1989-93. PubMed ID: 23242727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]